As personalized medicine and shorter product lifecycles become the standard, the pharmaceutical industry is grappling with both challenges and opportunities. Traditionally, New Product Introductions (NPIs) required extensive production lines to generate millions of doses, but the shift towards specialized medicines demands innovative manufacturing solutions. This evolution necessitates a departure from large-scale production, as manufacturers face complications such as increased machine downtime and elevated costs.
In response to these challenges, many pharmaceutical companies are adopting Late-Stage Customization (LSC) techniques. This approach allows for flexible packaging solutions that can adapt to real-time market demands, regulatory requirements, and language variations. By postponing the final packaging until the destination is known, manufacturers can minimize waste and costs while ensuring compliance and efficiency.
As the industry moves forward, the integration of advanced digital printing technologies and automation will likely solidify LSC as a new standard. The potential for enhanced efficiencies and sustainability in packaging solutions positions LSC as a critical strategy for pharmaceutical companies aiming to thrive in a rapidly changing market.
Open the full market picture for your next decision →
